For experienced investors looking for global opportunities

Latest Post

Venture: US Financial Software

Venture: US Financial Software

The global market rotation has been strong since May, particularly in the USA. Now, the market leaders are struggling while the weakest trends are bouncing back.


ByteTree Venture is an equity research service seeking deep value, momentum, or special situations around the world, run by ex-HSBC fund manager Charlie Morris. It is only available to ByteTree Pro clients.

Each company we recommend is tracked in a model portfolio and sold when appropriate, with clients notified of every change. Research is delivered weekly, typically on Mondays, but follows market conditions.

Venture focuses on value and momentum, mostly in global equities, but also commodities, as they can benefit from powerful moves. For example, here is a list of our past (closed) recommendations, up to 2025:

The portfolio has a higher risk tolerance than our other services, in search of higher returns. This is why it is limited to our Pro clients.

The Venture Portfolio

Venture was launched when undervalued UK small- and mid-cap stocks offered a significant opportunity. This discount came about following issues such as Brexit and the short-lived Liz Truss premiership, which kept international investors away. This resulted in many world-class companies trading at absurdly low valuations, making it a rich picking ground.

As the opportunity set broadened, our research tools improved, and our team grew, our ability to look for value and momentum more broadly led to a shift in strategy.

At ByteTree, we prefer giving concrete answers to ideas, as the accountability is higher. As a result, in Spring 2026, we shifted from the tip sheet style to a model portfolio approach. Moving forward, every quarter, we will publish our performance for clients and visitors alike.

Our portfolio (as of August 10, 2026) is 39% ahead of the World Index since late 2024, when it became fully invested.

Venture Portfolio Performance

So far, we have profited from opportunities in software, construction, fintech, pharmaceuticals, banking, broking, mining, media, airport caterers, biotech, and much more. To find great value in markets, you need to be flexible.

Investment Process

Financial markets are all about data and trends. We have spent decades refining our stock selection process, which is both quantitative and qualitative. That means we use data to identify good opportunities and then do detailed research into the company thereafter. We look for unusual relationships, such as valuations out of kilter with the past, or a discount to a vibrant sector of the market.

Screening is a powerful tool and a key part of the process. Rather than study 3,000 companies, which would require a small army of analysts, we use computers and data. They have never selected a stock, nor will they. Instead, they are a huge time-saving device that helps us identify potential opportunities.

An example might be that oil is strong, or Greece is recovering from a slump. By screening data, attractive potential outliers are identified before the recovery story has even evolved.

As you saw above, this process has led to some excellent returns for early clients. The team at ByteTree has since grown, and Charlie is now supported by Kit Winder CFA, but the process is identical, and we are able to uncover even more opportunities every week.

Boosted now by the trend-following insights of ByteTrend and Global Trends, we are able to identify which stocks are currently beating the index, in what sectors, and where, at record pace. There’s always value on offer somewhere, and pairing it with momentum is a powerful combination.

What's more, the 21st century has enabled the private investor to become ever more empowered. Today’s investment platforms give you access to a wide range of securities around the world at low cost. We intend to take advantage of that power, helping you invest in the best opportunities around the world.

Who Is Venture For?

Venture is best suited for confident and experienced investors, and is exclusive to ByteTree Pro clients, helping them identify profitable opportunities in global stock markets.

They have been generous with their praise on Trustpilot, for which we are exceptionally grateful.

ByteTree Pro includes Venture, along with access to everything we currently offer, from The Multi Asset Investor, to Quality and Global Trends.

We think it puts you in the best possible position to manage your wealth for the long term, covering portfolio management, the best companies in the world, and value opportunities, while keeping on top of the trends.

Our track record is strong, our process is robust, and the opportunities are wide-ranging.

Become a ByteTree Pro client today

Upgrade Now

About the Editor

ByteTree Research was founded by Charlie Morris, an experienced fund manager since 1997. At HSBC Global Asset Management in London, where he worked for 17 years, he managed $3 billion of institutional and private wealth. His funds invested in equities and bonds alongside alternative assets such as gold, commodities, real estate, credit, private equity, and hedge funds.

Recent Posts

Venture: USA Software

Venture: USA Software

The idea was that software would be disrupted by AI. We believe that view was overdone, and now the market agrees.

Venture: European Chemicals

Venture: European Chemicals

Following this trade, the ByteTree Venture Portfolio will be invested across 31 different companies and commodities. This latest chemical stock will fit into industrials, where we already have 9% invested.

Venture: Energy

Venture: Energy

Currently, it’s all about the energy mix. Heating oil is a heavy product, similar to diesel and jet fuel, where the market is tight.

Venture: Recruitment

Venture: Recruitment

This latest idea trades 89% below the share price high in 2000. Turnarounds can be highly profitable opportunities.

Venture: Biotechnology

Venture: Biotechnology

Issue 132; Biotech is still showing signs of strength, and we add another gem to the portfolio.

Venture: Biotechnology

Venture: Biotechnology

Issue 131; Biotech is on the move once again, and one small niche in particular. After the dotcom bust in